Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

Severe hair loss links to metabolic issues in older men with psoriasis.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Dual anti-seizure medications, especially valproic acid with lamotrigine, often cause more side effects like hair loss and memory issues.

Isotretinoin has many serious side effects, including some new ones, needing better safety measures and updated labels.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Avacopan may cause unexpected side effects, so early monitoring is important.

Oral minoxidil rarely causes pericardial effusion, especially at low doses.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

Minoxidil use increases facial hair growth in females, more in older users.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Valproic acid increases hair count in men with hair loss.

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.